Table 4.
Regulation Factor | Research Objects | Macrophage polarization | Mechanisms | Year and Country | Reference |
---|---|---|---|---|---|
Alleviating ALD | |||||
Cannabinoid CB2 receptor | Mice, cells | M1↓ | HO-1↑; NF-κB signaling↓ | 2011, France | (127) |
EV-miR-27a | Patient samples, cells | M2↑ | IL-10, TGF-β↑ | 2016, America | (134) |
β-caryophyllene | Mice | M1↓ | Cannabinoid 2 receptors↑; PPARα↑ | 2018, America | (140) |
β-hydroxybutyrate | Patient samples, mice, cells | M2↑ | Hcar2-cAMP pathway↑ | 2018, America | (141) |
Salidroside | Cells | M1↓ | Notch-Hes signaling pathway↓; NF-κB↓ | 2019, China | (142) |
Inulin | Mice, cells | M1↓; M2↑ | Short chain fatty acids↑; TLR4-MyD88-NF-κB pathway↓ | 2020, China | (138) |
Brain and Muscle Arnt-Like Protein-1 | Mice, cells | M1↓; M2↑ | S100A9 protein↑; glycolytic pathway↓ | 2021, China | (130) |
Metformin and Probiotics | Cells, rats | M1↓; M2↑ | MAPK/Nrf-2/HO-1 signaling pathway↑ | 2021, India | (139) |
Aggravating ALD | |||||
Telomerase reverse transcriptase | Mice, cells | M1↑ | NF-κB pathway↑ | 2016, China | (126) |
MiR-155 | Mice, cells | M1↑; M2↓ | PPARγ↓; C/EBPβ↓ | 2016, America | (143) |
Nogo-B | Patient samples, mice, cells | M1↑; M2↓ | C/EBP homologous protein↓; Endoplasmic reticulum stress↓ | 2017, America | (137) |
EV-Heat shock protein 90 | Mice, cells | M1↑; M2↓ | IκB kinase↑, TLR4/NF–κB pathway↑ | 2018, America | (133) |